I thought this space was already cornered by companies in India? That's where most of the world gets it cheap generics from, I think.
https://www.biospace.com/article/justice-department-charges-...
Also, from the web site:
- "We are hoping to introduce over 100 additional drugs by the end of 2021."
- "By 2022, building a pharmaceutical factory of our own in Dallas, TX"
I can't shake the feeling it's just a shallow rebranding play using a billionaire's personal brand. Perhaps many americans don't trust non-US brands, even when it comes to generics?
https://www.npr.org/sections/health-shots/2019/05/12/7222165...
It's extremely hard to enforce GMP and QA/QC from across the world and there's a strong incentive to cheat and lie when it comes to these costly procedures. Whether it'll be any better in a US manufacturing facility is of course up for debate.
> Because the FDA requires very specific GMP requirements that differ from those of the EU and other countries, drugs approved or synthesized without US FDA certification cannot be legally sold in the U.S.
Sounds a bit like trade protectionism - but I assume that goes both ways between e.g. EU and US.